Samsung BioLogics' First Trading Day - Blunders in Barron's Argument & Price Prediction
As reported by Barron's on Nov 5 ("Samsung BioLogics IPO: Too Expensive"), there are still some skeptical views on BioLogics' IPO valuation....
239 Views
One World, Two Stories
Celltrion's management continues to make very optimistic projections about Remsima's US sales in 2017 despite regulatory hurdles that will limit...
151 Views
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
261 Views
Samsung BioLogics IPO - Why Investors Are Excited & Concerned
Samsung BioLogics will have a big day tomorrow. Nov 2-3 will be the subscription day. The company has already had a huge success with the...
301 Views
Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider
Maeil Economic Daily, Korea's largest financial newspaper, has just reported that Samsung BioLogics' IPO price was set at ₩136,000, which is the...
256 Views